IL1B and inflammatory bowel disease: IL-1β is expressed at higher levels in both plasma and colonic mucosal tissue of patients with IBD (56), significantly enhancing the pro-inflammatory response by recruiting and activating immune cells within the intestinal mucosa (57, 58), and participating in the disruption of the intestinal barrier and modulating the differentiation and function of helper T (Th) cells.